AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Lyra Therapeutics, Inc.

$0.2 -$2.96 (-93.67%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.2
Day Range
$0.2$0.52
Year Range
$0$8.75
Market Cap
354.98K
AVG Volume
9.45K
Trailing/Forward PE
-0.01/-
PEG ratio
-0.02
Dividend Yield
-
Next Earnings Date
2026-11-17
Primary Exchange
Other OTCUS
Revenue (USD)
0500K1M1.5M2M2019202020212022202320242025
LYRA Revenue (USD) by year
PeriodRevenue (USD)
2025398K
20241.53M
20231.56M
20221.36M
2021285K
20200
20190
Net Income (USD)
-100M-75M-50M-25M02019202020212022202320242025
LYRA Net Income (USD) by year
PeriodNet Income (USD)
2025-28.92M
2024-93.44M
2023-62.68M
2022-55.28M
2021-43.51M
2020-22.13M
2019-16.31M
Operating Income (USD)
-100M-75M-50M-25M02019202020212022202320242025
LYRA Operating Income (USD) by year
PeriodOperating Income (USD)
2025-31.02M
2024-96.35M
2023-67.12M
2022-56.31M
2021-43.62M
2020-22.21M
2019-16.52M
EBITDA (USD)
-80M-60M-40M-20M02019202020212022202320242025
LYRA EBITDA (USD) by year
PeriodEBITDA (USD)
2025-27.75M
2024-60.26M
2023-64.96M
2022-53.92M
2021-42.61M
2020-22.11M
2019-16.49M
Cash Flows (USD)
-80M-60M-40M-20M02019202020212022202320242025
LYRA Cash Flows (USD) by year
PeriodCash Flows (USD)
2025-28.98M
2024-72.35M
2023-64.35M
2022-43.55M
2021-29.2M
2020-22.92M
2019-13.96M
EPS (USD)
-20-15-10-502019202020212022202320242025
LYRA EPS (USD) by year
PeriodEPS (USD)
2025-18.62
2024-1.43
2023-1.32
2022-2.19
2021-3.35
2020-1.94
2019-2.47
Expenses (USD)
020M40M60M80MR&DSG&ACapex2019202020212022202320242025
LYRA Expenses (USD) by year
PeriodExpenses (USD)
202529.97M
202464.47M
202368.05M
202255.82M
202147.38M
202023.98M
201916.73M
Cash & Debt (USD)
050M100M150MCashLong Term DebtShort Term Debt2019202020212022202320242025
LYRA Cash & Debt (USD) by year
PeriodCash & Debt (USD)
202515.89M
202440.58M
2023102.75M
202297.89M
202145.75M
202074.59M
20199.81M
Debt ratios
-0.200.20.40.60.82022202320242025
LYRA Debt ratios by year
PeriodDebt ratios
2025-0.07
20240.03
20230.41
20220.69
Margins
-15000%-10000%-5000%0%5000%20212022202320242025
LYRA Margins by year
PeriodMargins
2025100%
202491.13%
2023-1392.43%
2022-2060.6%
2021-10283.86%
Return on Capital
-1000%-500%0%500%2019202020212022202320242025
LYRA Return on Capital by year
PeriodReturn on Capital
2025269.84%
2024-805.89%
2023-70.1%
2022-68.45%
2021-126.8%
2020-29.7%
2019-222.52%
Shares Outstanding
020M40M60M80M2019202020212022202320242025
LYRA Shares Outstanding by year
PeriodShares Outstanding
202515.53M
202465.11M
202361.24M
202231.71M
202112.97M
202012.96M
20198.18M
Book Value Per Share (USD)
-202462019202020212022202320242025
LYRA Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2025-0.69
20240.18
20231.46
20222.55
20212.65
20205.75
20190.9
Total Assets (USD)
050M100M150M2019202020212022202320242025
LYRA Total Assets (USD) by year
PeriodTotal Assets (USD)
202536.11M
202466.35M
2023142.6M
2022109.97M
202154.87M
202080.83M
201914.96M
Employee Count
0255075100202020212022202320242025
LYRA Employee Count by year
PeriodEmployee Count
202527
202430
202388
202258
202153
202038
Free Cash Flow Yield
-20000%-15000%-10000%-5000%0%med -262.72%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
LYRA Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-932.59%
Sep 26-932.59%
Aug 26-932.59%
Aug 26-18651.76%
Aug 26-746.07%
Aug 26-548.58%
Jul 26-392.67%
Jul 26-358.69%
Jul 26-358.69%
Jul 26-345.79%
Jul 26-262.95%
Jun 26-310.86%
Jun 26-274.29%
Jun 26-339.12%
Jun 26-266.42%
May 26-252.05%
May 26-248.69%
May 26-248.69%
May 26-255.5%
May 26-252.08%
Apr 26-262.48%
Apr 26-231.81%
Apr 26-286.95%
Apr 26-380.42%
Mar 26-3935.81%
Mar 26-3937.41%
Mar 26-1461.62%
Mar 26-1507.29%
Feb 26-1910.23%
Feb 26-1330.57%
Feb 26-1388.01%
Feb 26-1060.07%
Jan 26-1083.89%
Jan 26-941.14%
Jan 26-969.51%
Jan 26-511.76%
Jan 26-610.55%
Dec 25-537.42%
Dec 25-535.93%
Dec 25-530.04%
Dec 25-451.83%
Nov 25-522.85%
Nov 25-599.17%
Nov 25-501.13%
Nov 25-691.95%
Oct 25-553.8%
Oct 25-500.77%
Oct 25-462.3%
Oct 25-415.89%
Oct 25-455.7%
Sep 25-493.03%
Sep 25-502.35%
Sep 25-507.14%
Sep 25-465.68%
Aug 25-455.7%
Aug 25-427.03%
Aug 25-452.47%
Aug 25-12.84%
Aug 25-13.08%
Jul 25-10.82%
Jul 25-10.89%
Jul 25-9.95%
Jul 25-9.56%
Jun 25-9.45%
Jun 25-8.23%
Jun 25-7.59%
Jun 25-3.54%
May 25-17.46%
May 25-18.75%
May 25-15.39%
May 25-17.53%
May 25-20.5%
Apr 25-21.16%
Apr 25-25.72%
Apr 25-21.74%
Apr 25-18.43%
Mar 25-16.01%
Mar 25-12.7%
Mar 25-12.92%
Mar 25-12.85%
Feb 25-11.55%
Feb 25-12.01%
Feb 25-11.87%
Feb 25-13.22%
Jan 25-13.52%
Jan 25-13.18%
Jan 25-12.97%
Jan 25-12.64%
Jan 25-11.88%
Dec 24-12.97%
Dec 24-13.73%
Dec 24-13.54%
Dec 24-11.5%
Nov 24-11.93%
Nov 24-13.08%
Nov 24-14.54%
Nov 24-9.01%
Nov 24-9.31%
Oct 24-9.64%
Oct 24-9.89%
Price to Sales
050010001500med 27.71Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
LYRA Price to Sales by year
PeriodPrice to Sales
Sep 267.81
Sep 267.81
Aug 267.81
Aug 260.39
Aug 269.76
Aug 2613.27
Jul 2618.54
Jul 2620.3
Jul 2620.3
Jul 2621.05
Jul 2627.69
Jun 2623.42
Jun 2626.54
Jun 2621.47
Jun 2627.33
May 2628.88
May 2629.27
May 2629.27
May 2628.49
May 2628.88
Apr 2627.74
Apr 2631.41
Apr 2625.37
Apr 2619.14
Mar 261.44
Mar 261.44
Mar 263.89
Mar 263.77
Feb 262.98
Feb 264.27
Feb 264.1
Feb 265.36
Jan 265.24
Jan 266.04
Jan 265.86
Jan 2611.11
Jan 269.31
Dec 2510.58
Dec 2510.61
Dec 2510.72
Dec 2512.58
Nov 2510.87
Nov 259.49
Nov 2511.34
Nov 258.07
Oct 2510.09
Oct 2511.16
Oct 2512.09
Oct 2513.43
Oct 2512.26
Sep 2511.33
Sep 2511.12
Sep 2511.02
Sep 2512
Aug 2512.26
Aug 2513.08
Aug 2512.35
Aug 25371.8
Aug 25365.14
Jul 25441.16
Jul 25438.39
Jul 25480
Jul 25499.43
Jun 25505.53
Jun 25579.89
Jun 25629.28
Jun 251347.34
May 25273.57
May 25254.71
May 25310.2
May 25272.47
May 25230.06
Apr 25222.85
Apr 25183.37
Apr 25216.9
Apr 25255.96
Mar 25294.58
Mar 25371.41
Mar 25365.05
Mar 25428.07
Feb 25476.13
Feb 25457.89
Feb 25463.23
Feb 25416.06
Jan 25406.71
Jan 25417.39
Jan 25424.07
Jan 25435.19
Jan 25462.78
Dec 24424.07
Dec 24400.48
Dec 24406.27
Dec 24478.35
Nov 24461
Nov 24420.51
Nov 24378.23
Nov 24481.24
Nov 24465.77
Oct 24449.59
Oct 24438.08
Price to Book
0200400600med 30.49Feb 24May 24Sep 24Dec 24Apr 25Jul 25Nov 25
LYRA Price to Book by year
PeriodPrice to Book
Nov 253.83
Oct 254.79
Oct 255.3
Oct 255.74
Oct 256.38
Oct 255.82
Sep 255.38
Sep 255.28
Sep 255.23
Sep 255.7
Aug 255.82
Aug 256.21
Aug 255.86
Aug 25113.79
Aug 25111.75
Jul 25135.01
Jul 25134.17
Jul 25146.9
Jul 25152.85
Jun 25154.71
Jun 25177.47
Jun 25192.59
Jun 25412.35
May 2583.73
May 2577.95
May 2594.93
May 2583.39
May 2530.44
Apr 2529.48
Apr 2524.26
Apr 2528.7
Apr 2533.87
Mar 2538.98
Mar 2549.14
Mar 2548.3
Mar 2530.54
Feb 2533.97
Feb 2532.67
Feb 2533.05
Feb 2529.68
Jan 2529.02
Jan 2529.78
Jan 2530.25
Jan 2531.05
Jan 2533.02
Dec 2430.25
Dec 2428.57
Dec 2428.98
Dec 2434.13
Nov 2432.89
Nov 2430
Nov 2426.98
Nov 2428.27
Nov 2427.37
Oct 2426.41
Oct 2425.74
Oct 2424.3
Oct 2425.08
Sep 2428.08
Sep 2429.8
Sep 2429.58
Sep 2428.82
Aug 2434
Aug 2433.39
Aug 2431.57
Aug 2412.39
Aug 2411.95
Jul 2412.7
Jul 2411.56
Jul 2412.02
Jul 2411.23
Jun 2411.43
Jun 2411.16
Jun 2412.19
Jun 2413.23
May 2413.54
May 2413.45
May 2415.82
May 2415.39
May 24166.42
Apr 24161.62
Apr 24177.71
Apr 24180.79
Apr 24171.89
Mar 24212.98
Mar 24213.66
Mar 24200.46
Mar 24179.5
Mar 24192.35
Feb 24179.17
Feb 24170.04
Feb 24164.97
Feb 24158.21
Jan 24163.28
Jan 24175.79
Jan 24181.87
Jan 24177.81
Dec 23177.14
Dec 23161.25
Dec 23157.19
Lyra Therapeutics, Inc.
LYRA
Stockpicker

Video analysis: LYRA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.